Abstract
Neuromyelitis optica (NMO) is a recurrent inflammatory disease that preferentially targets the optic nerves and spinal cord. The presence of antibodies to the water channel protein aquaporin-4 (AQP4), expressed almost exclusively in astrocytes in the central nervous system (CNS), is a reliable biomarker for NMO. These antibodies, NMO-IgG, may be responsible for the sequential cascade of immune events, including IgG/IgM deposition, infiltration of granulocytes and complement-mediated cytotoxicity (i.e. astrocyte loss) and demyelination. This review summarizes current thinking about the role of NMO-IgG in the pathogenesis of this condition. New insights were also generated along with important additional questions.
| Original language | English |
|---|---|
| Pages (from-to) | 63-70 |
| Journal | Journal of Neuroimmunology |
| Volume | 298 |
| Online published | 7 Jun 2016 |
| DOIs | |
| Publication status | Published - 15 Sept 2016 |
| Externally published | Yes |
Research Keywords
- Complement
- Demyelination
- Glutamate
- Neuromyelitis optica
- Potassium channel
- Water channel protein aquaporin-4
Fingerprint
Dive into the research topics of 'The role of AQP4 in neuromyelitis optica: More answers, more questions'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver